Benzyl-, (pyridin-3-yl)methyl- or (pyridin-4-yl)methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- BOEHRINGER INGELHEIM INT GMBH
- Publication Date
- 2020-09-11
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to: new Oxadiazolopyridine derivatives, which are inhibitors of ghrelin O-acyltransferase (GOAT); preparation methods of these compounds; pharmaceutical compositions comprising these compounds; and their use in the prevention and / or treatment of ghrelin Medicinal use for diseases affected by the modulation of the function of O-acyltransferases (GOATs). In particular, the pharmaceutical composition of the present invention is suitable for the prevention and / or treatment of metabolic diseases, such as obesity, including but not limited to obesity, insulin resistance and diabetes in patients with Prader-Willi syndrome (PWS), in particular is type 2 diabetes. Background technique
[0002] Ghrelin O-acyltransferase (GOAT) is a member of the membrane-embedded O-acyltransferase (MBOAT) protein family and the only enzyme in humans that can promote the acylation reaction of the peptide hormone ghrelin. By linking a medium-chain...